| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Country | Antigens | Description | Schedules | Entire country | Comments | ||||||||||||||||||||
2 | Americas | |||||||||||||||||||||||||
3 | Antigua and Barbuda | DT | Tetanus and diphtheria toxoid childrens' dose | 18 months; 4-5, 15 years; | Yes | 12 | ||||||||||||||||||||
4 | DTwP | Diphtheria and tetanus toxoid with whole cell pertussis vaccine | 18 months; | Yes | ||||||||||||||||||||||
5 | DTwPHibHepB | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
6 | DTwPHibHepBIPV | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B and Polio vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
7 | HepB_Adult | Hepatitis B adult dose vaccine | 1st contact; +6 weeks; +6 months; | Yes | ||||||||||||||||||||||
8 | HPV | Human Papillomavirus vaccine | 9 years; +6 months; | Yes | From November 2016 | |||||||||||||||||||||
9 | Influenza | Influenza vaccine | 30-37 months; | Yes | ||||||||||||||||||||||
10 | IPV | Inactivated polio vaccine | 2, 4 months; | Yes | From November 2015 | |||||||||||||||||||||
11 | MMR | Measles mumps and rubella vaccine | 12, 18 months; | Yes | ||||||||||||||||||||||
12 | OPV | Oral polio vaccine | 2, 4, 6, 18 months; 4-5 years; | Yes | ||||||||||||||||||||||
13 | Td | Tetanus and diphtheria toxoid for older children / adults vaccube | 1st contact; + 4 weeks; +6 months; | Yes | ||||||||||||||||||||||
14 | Varicella | Varicella vaccine | 2 years; | Yes | From June 2016 | |||||||||||||||||||||
15 | Argentina | BCG | Bacille Calmette-Guérin vaccine | Birth; | Yes | 22 | ||||||||||||||||||||
16 | CHOLERA | Cholera vaccine | Yes | militaries | ||||||||||||||||||||||
17 | DTwP | Diphtheria and tetanus toxoid with whole cell pertussis vaccine | 6 years; | Yes | ||||||||||||||||||||||
18 | DTwPHibHepB | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B vaccine | 2, 4, 6, 15-18 months; | Yes | ||||||||||||||||||||||
19 | HepA_Pediatric | Hepatitis A pediatric dose vaccine | 12 months; | Yes | ||||||||||||||||||||||
20 | HepB_Adult | Hepatitis B adult dose vaccine | Yes | |||||||||||||||||||||||
21 | HepB_Pediatric | Hepatitis B pediatric dose vaccine | birth; | Yes | ||||||||||||||||||||||
22 | HIB | Haemophilus influenzae type b vaccine | Yes | special groups | ||||||||||||||||||||||
23 | HPV | Human Papillomavirus vaccine | 11 years (x2); | Yes | ||||||||||||||||||||||
24 | Influenza_Adult | Influenza adult dose vaccine | > 65 years; | Yes | and adults with chronic diseases, pregnant women, health care workers and other risk groups | |||||||||||||||||||||
25 | Influenza_Pediatric | Influenza pediatric dose vaccine | 6-24 months; | Yes | and children with chronic diseases | |||||||||||||||||||||
26 | IPV | Inactivated polio vaccine | 2 months; | Yes | ||||||||||||||||||||||
27 | MenACWY-135 conj | Meningococcal ACWY-135 conjugate vaccine | 3, 5, 15 months; 11 years; | Yes | ||||||||||||||||||||||
28 | MMR | Measles mumps and rubella vaccine | 1, 6 years; | Yes | and Y11 if not yet vaccinated | |||||||||||||||||||||
29 | OPV | Oral polio vaccine | 4, 6, 15-18 months; 6 years; | Yes | ||||||||||||||||||||||
30 | Pneumo_conj | Pneumococcal conjugate vaccine | 2, 4, 12 months; | Yes | ||||||||||||||||||||||
31 | Pneumo_ps | Pneumococcal polysaccharide vaccine | > 65 years; | Yes | and risk groups | |||||||||||||||||||||
32 | Rotavirus | Rotavirus vaccine | 2, 4 months; | Yes | ||||||||||||||||||||||
33 | Td | Tetanus and diphtheria toxoid for older children / adults vaccube | Yes | adults every 10 years | ||||||||||||||||||||||
34 | Tdap | Tetanus and diphtheria toxoids and acellular pertussis vaccine | 11 years; | Yes | HCW and PW | |||||||||||||||||||||
35 | Varicella | Varicella vaccine | 15 months; | Yes | ||||||||||||||||||||||
36 | YF | Yellow fever vaccine | 18 months; | No | Risk areas and travelers | |||||||||||||||||||||
37 | Bahamas (the) | DTaPHibHepIPV | Hexavalent diphtheria, tetanus toxoid with acellular pertussis, Hib, hepatitis B and IPV vaccine | 2, 4, 6 months; | No | 16 | ||||||||||||||||||||
38 | DTaPHibIPV | Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine | 2, 4, 6 months; | No | ||||||||||||||||||||||
39 | DTwP | Diphtheria and tetanus toxoid with whole cell pertussis vaccine | 4-5 years; | Yes | ||||||||||||||||||||||
40 | DTwPHib | Diphtheria and tetanus toxoid with whole cell pertussis and Hib vaccine | 15 months; | Yes | ||||||||||||||||||||||
41 | DTwPHibHepB | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
42 | HPV | Human Papillomavirus vaccine | 9-15 years; | |||||||||||||||||||||||
43 | Influenza_Adult | Influenza adult dose vaccine | Yes | elderly, adults with chronic diseases, and pregnant women, health care workers | ||||||||||||||||||||||
44 | Influenza_Pediatric | Influenza pediatric dose vaccine | 6-35 months; | Yes | and children with chronic disease | |||||||||||||||||||||
45 | IPV | Inactivated polio vaccine | 2, 4 months; | Yes | ||||||||||||||||||||||
46 | MMR | Measles mumps and rubella vaccine | 1, 4-5 years; | Yes | ||||||||||||||||||||||
47 | OPV | Oral polio vaccine | 6 months; | Yes | ||||||||||||||||||||||
48 | Pneumo_conj | Pneumococcal conjugate vaccine | 2, 4, 6, 15 months; | Yes | ||||||||||||||||||||||
49 | Rotavirus | Rotavirus vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
50 | Td | Tetanus and diphtheria toxoid for older children / adults vaccube | 10-12 years; | Yes | every 10 years | |||||||||||||||||||||
51 | Tdap | Tetanus and diphtheria toxoids and acellular pertussis vaccine | 10-12 years; | Yes | every 10 years | |||||||||||||||||||||
52 | Varicella | Varicella vaccine | 1, 4-5 years; | Yes | ||||||||||||||||||||||
53 | Barbados | BCG | Bacille Calmette-Guérin vaccine | 5 years; | Yes | 14 | ||||||||||||||||||||
54 | DT | Tetanus and diphtheria toxoid childrens' dose | 5-7 years; | Yes | ||||||||||||||||||||||
55 | DTwP | Diphtheria and tetanus toxoid with whole cell pertussis vaccine | 18 months; 4.5 years; | Yes | ||||||||||||||||||||||
56 | DTwPHibHepB | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
57 | HepB_Adult | Hepatitis B adult dose vaccine | 1st contact; +1, +6 months; | Yes | Health care workers | |||||||||||||||||||||
58 | HPV | Human Papillomavirus vaccine | 11 years (x2); | Yes | ||||||||||||||||||||||
59 | Influenza_Adult | Influenza adult dose vaccine | >= 65 years; | Yes | health care workers and other risk groups | |||||||||||||||||||||
60 | IPV | Inactivated polio vaccine | 2, 4, 6, 18 months; 4.5, 10-11 years; | Yes | children of HIV mothers(from doses at 6M and after) | |||||||||||||||||||||
61 | MMR | Measles mumps and rubella vaccine | 12, 18 months; | Yes | ||||||||||||||||||||||
62 | OPV | Oral polio vaccine | 6, 18 months; 4.5, 10-11 years; | Yes | ||||||||||||||||||||||
63 | Pneumo_conj | Pneumococcal conjugate vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
64 | Td | Tetanus and diphtheria toxoid for older children / adults vaccube | 10-11 years; | Yes | ||||||||||||||||||||||
65 | Varicella | Varicella vaccine | 1 year; | Yes | ||||||||||||||||||||||
66 | YF | Yellow fever vaccine | Yes | Travelers | ||||||||||||||||||||||
67 | Belize | BCG | Bacille Calmette-Guérin vaccine | birth; | Yes | 15 | ||||||||||||||||||||
68 | DT | Tetanus and diphtheria toxoid childrens' dose | 2, 4, 6 months; 4 years; | Yes | contraindication to the Vaccine | |||||||||||||||||||||
69 | DTwP | Diphtheria and tetanus toxoid with whole cell pertussis vaccine | 4 years; | Yes | ||||||||||||||||||||||
70 | DTwPHibHepB | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
71 | HepB_Pediatric | Hepatitis B pediatric dose vaccine | birth; | Yes | From October 2017 | |||||||||||||||||||||
72 | HPV | Human Papillomavirus vaccine | 10 years; +6 months; | Yes | ||||||||||||||||||||||
73 | Influenza_Adult | Influenza adult dose vaccine | >= 65 years; | Yes | and adults with chronic diseases, pregnant women, health care workers | |||||||||||||||||||||
74 | Influenza_Pediatric | Influenza pediatric dose vaccine | 6-23 months; | Yes | and children with crhonic diseases | |||||||||||||||||||||
75 | IPV | Inactivated polio vaccine | 2, 4, 6 months; 4 years; | Yes | All children at M2, then Infants born to HIV positive mothers | |||||||||||||||||||||
76 | MMR | Measles mumps and rubella vaccine | 12, 18 months; | Yes | ||||||||||||||||||||||
77 | OPV | Oral polio vaccine | 4, 6, 18 months; 4 years; | Yes | ||||||||||||||||||||||
78 | Rotavirus | Rotavirus vaccine | Yes | Form November 2017 | ||||||||||||||||||||||
79 | Td | Tetanus and diphtheria toxoid for older children / adults vaccube | 1st contact; | Yes | pregnant women | |||||||||||||||||||||
80 | VitaminA | Vitamin A supplementation | 6, 12, 18, 24, 30, 36 months; | Yes | ||||||||||||||||||||||
81 | YF | Yellow fever vaccine | 1st contact; | No | travelling to endemic countries | |||||||||||||||||||||
82 | Bolivia (Plurinational State of) | BCG | Bacille Calmette-Guérin vaccine | birth; | Yes | 14 | ||||||||||||||||||||
83 | DTwPHibHepB | Diphtheria and Tetanus and Pertussis and Haemophilus influenzae and Hepatitis B vaccine | 2, 4, 6, 18 months; 4 years; | Yes | ||||||||||||||||||||||
84 | HepB_Adult | Hepatitis B adult dose vaccine | 1st contact, +1, +6 months; | Yes | health care workers | |||||||||||||||||||||
85 | HPV | Human Papillomavirus vaccine | Yes | From March 2017 | ||||||||||||||||||||||
86 | Influenza_Adult | Influenza adult dose vaccine | >= 65 years; | Yes | and adults with chronic diseases, pregnant women, health care workers and other risk groups | |||||||||||||||||||||
87 | Influenza_Pediatric | Influenza pediatric dose vaccine | 6-11, 12-23 months; | Yes | and children with chronic diseases | |||||||||||||||||||||
88 | MMR | Measles mumps and rubella vaccine | 12 months; | Yes | ||||||||||||||||||||||
89 | MR | Measles and rubella vaccine | Yes | risk groups | ||||||||||||||||||||||
90 | OPV | Oral polio vaccine | 2, 4, 6, 18 months; 4 years; | Yes | ||||||||||||||||||||||
91 | Pneumo_conj | Pneumococcal conjugate vaccine | 2, 4, 6 months; | Yes | ||||||||||||||||||||||
92 | Rotavirus | Rotavirus vaccine | 2, 4 months; | Yes | ||||||||||||||||||||||
93 | Td | Tetanus and diphtheria toxoid for older children / adults vaccube | 1st contact; +1, +6 months; +1, +1 year; | Yes | children from 7 to 10 years old and pregnant women | |||||||||||||||||||||
94 | VitaminA | Vitamin A supplementation | 6, 12, 18, 24, 30, 36 months; | Yes | ||||||||||||||||||||||
95 | YF | Yellow fever vaccine | 12 months; | Yes | ||||||||||||||||||||||
96 | Brazil | BCG | Bacille Calmette-Guérin vaccine | birth; | Yes | 28 | ||||||||||||||||||||
97 | CHOLERA | Cholera vaccine | >= 18 years (x2 doses); | Yes | Military | |||||||||||||||||||||
98 | DT | Tetanus and diphtheria toxoid childrens' dose | 2, 4, 6 months; | Yes | risk groups | |||||||||||||||||||||
99 | DTaPHepBIPV | Diphtheria and Tetanus and Pertussis and Hepatitis B and Polio | private sector | |||||||||||||||||||||||
100 | DTaPHibHepIPV | Hexavalent diphtheria, tetanus toxoid with acellular pertussis, Hib, hepatitis B and IPV vaccine | private sector | |||||||||||||||||||||||